Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial
Kristeleit, R. Clamp, Andrew R Gourley, C. Roux, R. Hall, M. Devlin, M. J. Nirsimloo, R. Kounnis, V. Hughes, L. Counsell, N.
Kristeleit, R.
Clamp, Andrew R
Gourley, C.
Roux, R.
Hall, M.
Devlin, M. J.
Nirsimloo, R.
Kounnis, V.
Hughes, L.
Counsell, N.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Kristeleit R, Clamp AR, Gourley C, Roux R, Hall M, Devlin MJ, et al. Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial. Annals of Oncology. 2022 Sep;33(7):S783-S. PubMed PMID: WOS:000866211600514.